Literature DB >> 16982565

4D imaging for target definition in stereotactic radiotherapy for lung cancer.

Ben J Slotman1, Frank J Lagerwaard, Suresh Senan.   

Abstract

Stereotactic radiotherapy of Stage I lung tumors has been reported to result in high local control rates that are far superior to those obtained with conventional radiotherapy techniques, and which approach those achieved with primary surgery. Breathing-induced motion of tumor and target tissues is an important issue in this technique and careful attention should be paid to the contouring and the generation of individualized margins. We describe our experience with the use of 4DCT scanning for this group of patients, the use of post-processing tools and the potential benefits of respiratory gating.

Entities:  

Mesh:

Year:  2006        PMID: 16982565     DOI: 10.1080/02841860600902817

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  17 in total

1.  Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.

Authors:  Edward D Brandner; Indrin J Chetty; Tawfik G Giaddui; Ying Xiao; M Saiful Huq
Journal:  Med Phys       Date:  2017-04-20       Impact factor: 4.071

2.  Imaging for high-precision thoracic radiotherapy.

Authors:  Sashendra Senthi; Suresh Senan
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

Review 3.  Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.

Authors:  Carri K Glide-Hurst; Indrin J Chetty
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

4.  Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Authors:  Ben J Slotman
Journal:  J Radiosurg SBRT       Date:  2011

Review 5.  Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.

Authors:  Adam Maciejczyk; Iga Skrzypczyńska; Marzena Janiszewska
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17

6.  No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.

Authors:  Serena Badellino; Jacopo Di Muzio; Giulia Schivazappa; Alessia Guarneri; Riccardo Ragona; Sara Bartoncini; Elisabetta Trino; Andrea Riccardo Filippi; Paolo Fonio; Umberto Ricardi
Journal:  Br J Radiol       Date:  2017-09-04       Impact factor: 3.039

7.  Toward a planning scheme for emission guided radiation therapy (EGRT): FDG based tumor tracking in a metastatic breast cancer patient.

Authors:  Qiyong Fan; Akshay Nanduri; Jaewon Yang; Tokihiro Yamamoto; Billy Loo; Edward Graves; Lei Zhu; Samuel Mazin
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

Review 8.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 9.  The clinical significance and management of lesion motion due to respiration during PET/CT scanning.

Authors:  Jason Callahan; Tomas Kron; Michal Schneider-Kolsky; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2011-12-28       Impact factor: 3.909

10.  Usefulness of target delineation based on the two extreme phases of a four-dimensional computed tomography scan in stereotactic body radiation therapy for lung cancer.

Authors:  Seong Soon Jang; Gil Ja Huh; Suk Young Park; Po Song Yang; EunYoun Cho
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.